Scientists have recently crafted and taken images of a novel new magnetic substance known as an altermagnetic material

When it comes to the state of the climate, a new study finds that our fear over the planet’s health may be “greatly overestimated”

Newton’s laws were the foundation of modern physics but because of the beliefs accepted at the time, they are wrong

We are all familiar by now with the various efforts that are underway to govern what we are allowed to say, and share, online

California Gov. Gavin Newsom on Wednesday declared a state of emergency for H5N1 avian influenza, commonly known as “bird flu.”

Normally, when Pfizer’s own study shows their vaccines increase your risk of serious adverse events and those effects are both large and statistically significant, you would think that would be reported by The New York Times, right?

NHS hospitals are telling patients, visitors and staff to wear face masks due to rising levels of winter bugs and low vaccine take-up, despite the lack of good evidence that they work

Cost-benefit analyses affirm it would be better to abandon Net Zero policy initiatives and instead “do nothing” about greenhouse gas emissions. [emphasis, links added]

Formaldehyde often poses the greatest risk in the one place people feel safest: inside their homes. The EPA has known for more than four decades that formaldehyde is toxic, but the companies that rely on it have thwarted the agency’s attempts to limit the chemical

CRISPR is one of the latest genetic tools that allows scientists to make changes to DNA, the molecule that carries the instructions for how living things grow and function.

The ProgenaBiome and McCullough Foundation study titled Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients

This morning’s edition of the New York Times features a cover story under the headline Giant Companies Took Secret Payments to Allow Free Flow of Opioids about a gross and obvious element of corruption that amplified America’s opioid crisis. To quote the piece:

Diabetes patients who took Ozempic were more than twice as likely to develop an eye condition that causes vision loss than patients using a different diabetes drug, according to a new study.

For the past five years, I ran the Institute for Cross-Disciplinary Engagement at Dartmouth, an initiative sponsored by the John Templeton Foundation